# Urokinase

## UROKINASE 60，000IU

##### 

| Title              | Content                                                                                                                                                                                                                                                       |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | IUROK                                                                                                                                                                                                                                                         |
| Indications        | Acute coronary embolism， clearance of occluded catheters & shunts， acute pulmonary embolism， peripheral arterial or venous thromboembolism.                                                                                                                |
| Dosing             | 60000-240000 IU on the first day， then decrease the dose day by day for about 7 days.                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                 |
| Contraindications  | Intracranial hemorrhage， hemoptysis， difficulty in hemostatic management; undergone intracranial or spinal surgery or with such injury (in the last 2 months); aneurysm; serious disturbance of consciousness.                                              |
| Adverse Effects    | Bleeding tendency. Fever， chills， headache & malaise may occur. Rarely， shock， sweating， disturbed pulse & dyspnea; rash， urticaria;nausea; vomiting & anorexia; abnormal liver function test; hematuria. Hematologic: Decreased hematocrit level (37%) |
| Pregnancy          | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                 |

